# Trialtone

*/Startups/Trialtone*

## Startup Overview

This system extracts acoustic biomarkers directly from standard patient phone calls. By analyzing vocal patterns, pitch, and speech rates during normal conversations, it identifies neurological and respiratory markers without requiring specialized recording hardware. The platform integrates into existing clinical trial check-in protocols to measure patient health continuously.

Clinical trial operators require objective data to track patient progression, but standard clinical assessments demand active participation and in-person visits. This creates friction and limits the frequency of data collection. By capturing data during routine phone interactions, the software removes the need for participants to download separate applications, learn new interfaces, or perform dedicated vocal exercises.

Where competitors like Winterlight Labs and Sonde Health require active speech tasks and specific smart devices, this approach is completely passive and device-agnostic. Trial participants speak into any standard landline or mobile phone. The software processes the audio in the background, delivering continuous, objective longitudinal data to researchers without altering the patient experience.

## Startup Founding Hypothesis

**Approach**: that extracts acoustic biomarkers from standard patient phone calls
**Competitors**:
- [Winterlight Labs](/Competitors/Winterlight_Labs)
- [Sonde Health](/Competitors/Sonde_Health)
- [Standard clinical assessments](/Competitors/Standard_clinical_assessments)
**Differentiator2x2**: device-agnostic for trial participants and completely passive in capture

## Startup Solution Coordinate

**Solution**: [Trialtone Acoustic Engine](/Software/Trialtone_Acoustic_Engine)

## Startup Position2x2

```mermaid
quadrantChart
x-axis "Hardware Dependent" --> "Device Agnostic"
y-axis "Active Assessment" --> "Passive Capture"
"Standard clinical assessments": [0.15, 0.15]
"Winterlight Labs": [0.65, 0.25]
"Sonde Health": [0.80, 0.35]
"Trialtone": [0.85, 0.85]
```

## Startup Offer

**Proof**:
- Targeting 90%+ patient monitoring compliance by eliminating the need for specialized apps or hardware.
- Aiming to achieve >85% correlation with standard in-clinic cognitive assessment scores using completely passive voice capture.
- Designing for zero-device-provisioning deployments to eliminate hardware logistics costs for trial sponsors.
**Tiers**:
- Name: Pilot Cohort · Price: ~$45–$80 per participant/month · Inclusions: Passive acoustic monitoring for up to 50 trial participants, single biomarker panel (e.g., cognitive or respiratory), and standard daily biomarker trend reporting.
- Name: Scale Trial · Price: ~$90–$150 per participant/month · Inclusions: Monitoring for 50+ participants, multi-condition acoustic tracking, raw metadata export, and intended API integration for standard Electronic Data Capture (EDC) systems.
- Name: Custom Model · Price: Custom configuration fee + per-participant usage · Inclusions: Tailored acoustic model training for novel indications, dedicated biostatistician support, and custom data-pipeline configuration for enterprise CROs.
**Guarantee**: If the acoustic capture engine fails to yield classifiable biomarker metadata for more than 5% of successfully connected participant calls in a given month, Trialtone waives the monitoring fees for those affected participants for that billing cycle.
**Business Function**: ProvideService
**Objection Handlers**:
- Objection: Patient privacy and HIPAA/GDPR compliance with voice recordings. Rebuttal: Audio pipelines are designed to instantly extract acoustic metadata and scrub vocal files; raw conversations are never retained in the system.
- Objection: Background noise on standard telecom networks will corrupt the biomarker data. Rebuttal: The extraction engine utilizes noise-gating and signal isolation trained specifically on low-fidelity cellular and VoIP audio.
- Objection: Regulators will not accept digital acoustic biomarkers as primary trial endpoints. Rebuttal: Trialtone is deployed today for exploratory endpoints and participant stratification, building the real-world evidence required for future regulatory qualification.
- Objection: Older trial populations struggle with new technology. Rebuttal: The system requires absolutely no action from the patient beyond answering their standard scheduled phone check-ins.
**Pricing Architecture**: UsageMeter
**Agent Checkout Support**:
- agentic-commerce-protocol

## Startup Brand

**Voice**: Clinical and precise register driven by absolute scientific rigor
**Tagline**: Capture acoustic biomarkers passively from everyday patient phone calls
**Icon Concept**: handset
**Palette Intent**: institutional-cool
**Visual Identity**: The brand pairs clinical slate blues and crisp whites with subtle audio-frequency patterns to project medical reliability and analytical precision
**Archetype Reference**: the-sage

## Startup Buyer Chain

**Chain**: Trialtone → Pharmaceutical Sponsor → Clinical Research Organization → Trial Participant
**Gtm Motion**: Direct outbound sales targeting Clinical Innovation Directors at pharma sponsors to secure a paid Phase II pilot. Expansion triggers when the sponsor validates the acoustic data and standardizes the endpoint across their broader decentralized trial portfolio.
**Agent Channel**: Designed to list a structured capability schema in the eClinical Forum digital endpoint registry, allowing automated protocol-design agents to parse the biomarker specifications and slot the service into trial workflows.
**Primary Channel**: Presentations at specialized clinical operations events like CNS Summit and SCOPE, where decentralized trial managers actively evaluate novel digital biomarkers for upcoming study protocols.

## Startup Customer Journey

```mermaid
flowchart LR; A[Clinical Ops Event] --> B[Phase II Pilot]; B --> C[Biomarker Extraction Engine]; C --> D[EDC System]; D --> E[Decentralized Trial Portfolio]; E --> F[Real-World Evidence Registry];
```

## Startup Proof Points

_Illustrative — target and order-of-magnitude estimate figures, not an achieved track record (this Thing is concept-stage)._

**Pilot Goals**:
- A 12-week observational pilot with up to 50 patients to validate that background noise isolation on standard cellular calls yields usable cognitive biomarker metadata in over 95 percent of scheduled check-ins.
- A 6-month exploratory endpoint pilot alongside a traditional trial to demonstrate that passive acoustic capture exports metadata seamlessly into standard Electronic Data Capture systems.
**Target Metrics**:
- Target: greater than 90 percent patient monitoring compliance rate compared to traditional app-based symptom reporting.
- Aim: greater than 85 percent correlation score between extracted acoustic metadata and standard in-clinic cognitive assessments.
- Target: zero additional hardware devices provisioned per decentralized trial participant.
- Aim: less than 5 percent classification failure rate across standard low-fidelity cellular network calls.
**Target Case Studies**:
- A mid-sized Contract Research Organization managing neurology trials replacing in-clinic assessments with passive acoustic tracking to increase data density without adding patient burden.
- A biopharma sponsor running respiratory trials utilizing standard scheduled phone check-ins to capture continuous acoustic metadata, eliminating the need to ship dedicated monitoring hardware.
- A decentralized clinical trial platform provider integrating passive voice capture into existing tele-visit workflows to extract exploratory endpoints without requiring secondary patient apps.
**Testimonial Targets**:
- A Principal Investigator expressing that passive voice tracking provides rich continuous data without overwhelming elderly patients with new technology.
- A Head of Clinical Operations stating that instantly scrubbing raw audio to extract only metadata completely satisfies their rigorous data privacy and HIPAA requirements.
- A Trial Coordinator emphasizing how zero-device-provisioning completely eliminates their usual hardware logistics and IT support tickets.

## Startup Top Risks

**Risks**:
- Severity: existential · Description: Standard cellular network audio compression degrades the specific vocal frequencies required to isolate accurate acoustic biomarkers. · Mitigation Status: unmitigated
- Severity: high · Description: FDA and EMA regulators reject passive acoustic endpoints as valid clinical measures for drug efficacy submissions. · Mitigation Status: in-progress
- Severity: high · Description: Institutional Review Boards classify passive background recording of trial participant calls as a privacy violation, requiring active prompts that destroy the passive capture differentiator. · Mitigation Status: unmitigated
- Severity: moderate · Description: Unpredictable ambient noise in real-world patient phone calls prevents the algorithm from establishing a consistent vocal baseline. · Mitigation Status: in-progress

## Startup Competitors

- [Winterlight Labs](/Competitors/Winterlight_Labs) — Active Speech Analysis
- [Sonde Health](/Competitors/Sonde_Health) — Voice Biomarker Platform
- [Standard Clinical Assessments](/Competitors/Standard_Clinical_Assessments) — Status Quo
- [Canary Speech](/Competitors/Canary_Speech) — Vocal Biomarkers
- [Aural Analytics](/Competitors/Aural_Analytics) — Clinical Speech Analytics

## Startup Solution Stack

- [Biomarker Extraction Service](/Services/Biomarker_Extraction_Service) — Service-as-Software
- [Acoustic Analysis Agent](/Agents/Acoustic_Analysis_Agent) — Agent
- [Call Telemetry Worker](/Agents/Call_Telemetry_Worker) — Agent
- [Audio Ingestion API](/Software/Audio_Ingestion_API) — Software
- [Device Agnostic SDK](/Software/Device_Agnostic_SDK) — Software

## Startup Story Brand

**Hero**:
- **Need**: to be the innovative scientist who solves patient retention, not the logistics coordinator
- **Want**: to capture high-frequency patient health data without shipping specialized hardware or devices
- **Identity**: the clinical trial lead at a mid-sized contract research organization
**Plan**:
- Step: Identify biomarkers · Detail: Select the cognitive or respiratory panels required for your specific decentralized trial indications.
- Step: Validate data · Detail: Review the daily biomarker trend reports generated automatically from standard patient phone check-ins.
- Step: Export results · Detail: Sync raw biomarker metadata directly into your Electronic Data Capture system for final analysis.
**Guide**:
- **Empathy**: Does your patient monitoring still suffer from low compliance because of difficult hardware setup?
**Problem**:
- **Villain**: hardware logistics
- **External**: Monitoring cognitive or respiratory health in a decentralized trial requires shipping tablets, headsets, and sensors that patients often fail to use correctly.
- **Internal**: You feel like a supply chain manager instead of a clinical researcher when data gaps ruin your endpoints.
- **Philosophical**: Every researcher deserves objective health data — not a warehouse full of unreturned medical equipment.
**Success**: Clinical endpoints are populated daily with objective acoustic data captured passively from existing patient routines.
**One Liner**: What if monitoring trial health required zero patient hardware? Trialtone extracts acoustic biomarkers from standard phone calls, delivering objective daily data without the logistics of shipping devices.
**Positioning**:
- **So That**: capture objective health trends through passive patient voice
- **Unlike**: specialized clinical assessment hardware
- **For Whom**: clinical trial leads at mid-sized CROs
- **Category**: Acoustic biomarker monitoring
**Call To Action**:
- **Direct**: Launch Pilot Cohort
- **Transitional**: Review Biomarker Panel
**Failure Stakes**:
- Incomplete endpoint data
- High participant dropout rates
- Ballooning hardware shipping costs
**Transformation**:
- **To**: monitoring health data passively instead of managing device logistics
- **From**: a trial lead managing tablet shipments and troubleshooting apps
**Controlling Idea**: Patient health data should come from existing routines, not new hardware.

## Startup Token Hero

**Genre**: founding-hypothesis
**Rendered**: What if monitoring trial health required zero patient hardware? Trialtone extracts acoustic biomarkers from standard phone calls, delivering objective daily data without the logistics of shipping devices.
**Mechanism**: spine-derived-v1
**Template Id**: spine-founding-hypothesis
**Vocab Fingerprint**: 7e224037d1fd1b75

## Startup Token Positioning

**Genre**: moore-positioning
**Rendered**: Acoustic biomarker monitoring for clinical trial leads at mid-sized CROs. Unlike specialized clinical assessment hardware — capture objective health trends through passive patient voice.
**Mechanism**: spine-derived-v1
**Template Id**: spine-moore-positioning
**Vocab Fingerprint**: 7a6b362c27cb342b

## Startup Token Pitch Deck

**Genre**: pitch-deck
**Rendered**: Problem: Monitoring cognitive or respiratory health in a decentralized trial requires shipping tablets, headsets, and sensors that patients often fail to use correctly.
Solution: What if monitoring trial health required zero patient hardware? Trialtone extracts acoustic biomarkers from standard phone calls, delivering objective daily data without the logistics of shipping devices.
Customer: clinical trial leads at mid-sized CROs
Unlike: specialized clinical assessment hardware
**Mechanism**: spine-derived-v1
**Template Id**: spine-pitch-deck
**Vocab Fingerprint**: 7493f64916082fc5

## Startup Token M E D D P I C C

**Pain**: Monitoring cognitive or respiratory health in a decentralized trial requires shipping tablets, headsets, and sensors that patients often fail to use correctly.
**Metrics**: Target: Clinical endpoints are populated daily with objective acoustic data captured passively from existing patient routines.
**Rendered**: Pain: Monitoring cognitive or respiratory health in a decentralized trial requires shipping tablets, headsets, and sensors that patients often fail to use correctly.
Economic buyer: Pharmaceutical Sponsor
Metrics: Target: Clinical endpoints are populated daily with objective acoustic data captured passively from existing patient routines.
Competition: specialized clinical assessment hardware
**Mechanism**: spine-derived-v1
**Competition**: specialized clinical assessment hardware
**Economic Buyer**: Pharmaceutical Sponsor
**Vocab Fingerprint**: 49e2458785735e79

## Startup Token Cold Email

**Genre**: cold-email
**Rendered**: Subject: Acoustic biomarker monitoring for clinical trial leads at mid-sized CROs

clinical trial leads at mid-sized CROs — Monitoring cognitive or respiratory health in a decentralized trial requires shipping tablets, headsets, and sensors that patients often fail to use correctly. What if monitoring trial health required zero patient hardware? Trialtone extracts acoustic biomarkers from standard phone calls, delivering objective daily data without the logistics of shipping devices.
**Mechanism**: spine-derived-v1
**Template Id**: spine-cold-email
**Vocab Fingerprint**: 0b0d1752a1a855d8

## Startup Token Agent Spec

**Genre**: ai-agent-spec
**Rendered**: Acoustic biomarker monitoring. What if monitoring trial health required zero patient hardware? Trialtone extracts acoustic biomarkers from standard phone calls, delivering objective daily data without the logistics of shipping devices. Serves clinical trial leads at mid-sized CROs.
**Mechanism**: spine-derived-v1
**Template Id**: spine-ai-agent-spec
**Vocab Fingerprint**: 8af0cf740b88303e

## Neighborhood

### Candidate solutions

- [Billable Hour Revenue Ceilings](/Problems/Billable_Hour_Revenue_Ceilings) — candidate solution for · Problems

### Composed of

- [Device Agnostic SDK](/Software/Device_Agnostic_SDK) — composes · Software
- [Biomarker Extraction Service](/Services/Biomarker_Extraction_Service) — composes · Services
- [Acoustic Analysis Agent](/Agents/Acoustic_Analysis_Agent) — composes · Agents
- [Call Telemetry Worker](/Agents/Call_Telemetry_Worker) — composes · Agents
- [Audio Ingestion API](/Software/Audio_Ingestion_API) — composes · Software

### Embodies

- [Software](/Theses/Software) — embodies · Theses

### What it offers

- [Trialtone Acoustic Engine](/Software/Trialtone_Acoustic_Engine) — offers · Software

### Competitors

- [Sonde Health](/Competitors/Sonde_Health) — competes with · Competitors
- [Standard Clinical Assessments](/Competitors/Standard_Clinical_Assessments) — competes with · Competitors
- [Canary Speech](/Competitors/Canary_Speech) — competes with · Competitors
- [Aural Analytics](/Competitors/Aural_Analytics) — competes with · Competitors
- [Winterlight Labs](/Competitors/Winterlight_Labs) — competes with · Competitors

### Similar Startups

- [Auronic](/Startups/Auronic) — similar · Startups
- [Adherenceside](/Startups/Adherenceside) — similar · Startups
- [Chronicmark](/Startups/Chronicmark) — similar · Startups
- [Trialgate](/Startups/Trialgate) — similar · Startups
- [Thrivevessel](/Startups/Thrivevessel) — similar · Startups
- [Luminouspatient](/Startups/Luminouspatient) — similar · Startups
- [Vitade](/Startups/Vitade) — similar · Startups
- [Chronic](/Startups/Chronic) — similar · Startups
- [Diagnace](/Startups/Diagnace) — similar · Startups
- [Vivum](/Startups/Vivum) — similar · Startups
- [Beacechanics](/Startups/Beacechanics) — similar · Startups
- [Voxent](/Startups/Voxent) — similar · Startups
- [Chronicinsight](/Startups/Chronicinsight) — similar · Startups
- [Tonetail](/Startups/Tonetail) — similar · Startups
- [Chronicsight](/Startups/Chronicsight) — similar · Startups
- [Bodyridge](/Startups/Bodyridge) — similar · Startups
- [Capturepad](/Startups/Capturepad) — similar · Startups
- [Accare](/Startups/Accare) — similar · Startups
- [Chronicgate](/Startups/Chronicgate) — similar · Startups
- [Chronichaven](/Startups/Chronichaven) — similar · Startups